HomeBVAXF • OTCMKTS
add
Biovaxys Technology Corp
Previous close
$0.020
Day range
$0.017 - $0.020
Year range
$0.015 - $0.060
Market cap
8.25M CAD
Avg Volume
502.94K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Apr 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.22M | 151.41% |
Net income | -1.32M | -142.76% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Apr 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.31K | -97.30% |
Total assets | 1.10M | -37.70% |
Total liabilities | 3.83M | 37.26% |
Total equity | -2.73M | — |
Shares outstanding | 291.53M | — |
Price to book | -1.97 | — |
Return on assets | -256.59% | — |
Return on capital | 143.03% | — |
Cash Flow
Net change in cash
| (CAD) | Apr 2025info | Y/Y change |
|---|---|---|
Net income | -1.32M | -142.76% |
Cash from operations | -8.17K | 98.13% |
Cash from investing | -1.06M | 0.00% |
Cash from financing | 903.54K | 31.34% |
Net change in cash | -153.11K | 80.99% |
Free cash flow | -908.69K | 18.14% |
About
Headquarters
Website
